SIGLEC1 and viral infectious disease: To determine whether these effects were recapitulated in the context of a viral infection, we tested the effects of different LEN levels on THP-1 cells treated with HIV-1-GFP and tracked both infectivity and innate immune activation, as measured by induction of two different interferon-stimulated genes (ISGs): ISG15 and SIGLEC1 (Fig. 4B,C).